glp-1 and substance use disorder More full stomachs? Less with GLP1s? "Conclusions: Use of receptor agonists was consistently associated with reduced risks of developing various incident SUDs, suggesting a broad preventive effect across GLP-1 Drugs Linked to Lower

Get Personalized Guidance from FormBlends Combining peptide therapy with GLP-1 medications requires expert oversight

Alpha Hydroxy Acids (AHAs) AHAs, such as glycolic acid and lactic acid, are chemical exfoliants that work by dissolving the bonds between dead skin cells, revealing smoother, brighter skin underneath

If you're on insulin or sulfonylureas, pre-meal cagrilintide dosing can increase hypoglycemia risk

(Article in Japanese) Komada N, Sakoda S, Iguchi A, et al

Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: a community-based cross-sectional study